Pure populations of human basophilic granulocytes were obtained from chronic myeloid leukemia (CML) blood by negative selection using a mixture of monoclonal antibodies and complement. '25Iradiolabeled recombinant human interleukin 3 (rhIL-3) bound to purified basophils in a specific manner. Quantitative binding studies and Scatchard plot analyses performed on samples from two donors revealed the presence of a single class of high-affinity IL-3 binding sites (500 and 2100 sites per cell; dissociation constant at equilibrium, 230 and 160 pmol/liter, respectively). Purified CML basophils maintained in suspension in the presence of rhIL-3 (100 units/ml) incorporated up to 12 times more [Hlthymidine than basophils in control cultures. Furthermore, after preincubation in vitro with rhIL-3 (100 units/mi) for 30 min, normal blood basophils released 2-to 3-fold more histamine than basophils pretreated with control medium when exposed to various concentrations ofan anti-IgE antibody. Together, these results show that rhIL-3 binds to a specific receptor on blood basophils and is a regulator of basophil function.
Blood basophils are circulating effector cells of allergic reactions (1) . They store mediators of allergy, which are released into the extracellular space under certain conditions (2) (3) (4) (5) . Factors regulating histamine release from basophils include a variety ofbioactive compounds (for review, see ref. 6 ). Most significantly, IgE molecules mediate basophil histamine release via specific surface membrane receptors (2) (3) (4) (5) . Recent data suggest that T-cell activation products regulate growth and function of human basophils (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Interleukin 3 (IL-3), a multipotential lymphokine, has been shown to support differentiation of human basophils from their precursors in bone marrow and cord blood (14) (15) (16) . Reports on a potential role for IL-3 in regulating histamine release from human blood basophils have been controversial (12) (13) (14) . Whereas Haak-Frendscho et al. (12) described histamine release from blood basophils in direct response to recombinant human IL-3 (rhIL-3) as well as recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF), no direct histamine-releasing activity of these cytokines was found in our own experiments (14) . More recently, Hirai et al. (13) reported that the histamine release from normal blood basophils induced by various stimuli such as anti-IgE antibodies could be enhanced by preincubation of basophils with rhIL-3 or rhGM-CSF. However, the mechanisms by which rhIL-3 and rhGM-CSF stimulate human blood basophils remain unclear.
So far, little has been reported about the expression of cytokine receptors on human basophils. The immunological phenotype of blood basophils suggests that they express receptors for . In this study, we investigated whether purified chronic myeloid leukemia (CML) basophils express receptors for IL-3 and GM-CSF and analyzed the effect of rhIL-2, rhIL-3, and rhGM-CSF on the functional properties of human basophils. (20) , VID-1 (anti-HLA-DR) (21), VIM-12 (CD11b) (22) , VIE-G4 (anti-glycophorin A) (23), VIM-D5 (CD15) (24) , and VIB-C5 (CD24) (25) . mAb anti-TAC (CD25) (26) was a kind gift from T. A. Waldman, LICR LON R10 (anti-glycophorin A) (27) was from D. J. Anstee, and CLB-ERY3 (anti-blood group H) was from P. T. Tetteroo. Anti-mast cell mAb YB5B8 (anti-150 kDa) (28) kindly provided by L. K. Ashman and MAX1 (anti-65 kDa) (29, 30) by trypan blue exclusion and could be maintained in culture for at least 9 days without substantial loss of cell viability.
Binding of Radiolabeled IL-3 and GM-CSF to Purified CML Basophils. Purified CML basophils of two donors were investigated for expression of specific IL-3 binding sites. Cells were incubated with increasing concentrations of iodinated rhIL-3 or rhGM-CSF. Fig. LA shows specific binding of radiolabeled rhIL-3 to basophils of donor 1. A linear Scatchard transformation curve suggests a single class of IL-3 binding sites. As calculated from Scatchard plots a single CML basophil was found to express -500 IL-3 binding sites in donor 1 (Fig. 1B) and -2100 IL-3 binding sites in donor 2 (data not shown). The dissociation constants were :230 pM (donor 1) and =160 pM (donor 2). CML basophils failed to specifically bind significant amounts of 125I-labeled rhGM-CSF. In contrast, neutrophils enriched from two healthy volunteers were found to bind -2500 and =3100 125I-labeled rhGM-CSF molecules per cell, whereas they did not bind significant amounts of 1251-labeled rhIL-3 (data not shown).
Effect of Cytokines on Thymidine Uptake by Enriched CML Basophils. CML basophils were found to incorporate higher amounts of [3H]thymidine when exposed to rhIL-3 (100 units/ml) in suspension compared to exposure to control medium (Table 1 ). In contrast, no effect of rhIL-2 and rhGM-CSF on thymidine uptake by CML basophils was observed. IL-3-induced [3H]thymidine uptake by basophils reached maximum levels by day 5 and declined between days 5 and 9 (see Table 1 ). The effect of rhIL-3 on [3H]thymidine uptake by basophils was found to be dose dependent (data not shown).
Effect of Cytokines on Surface Marker Expression of Enriched CML Basophils. Purified CML basophils of three donors were cultured in the presence of rhIL-2, rhIL-3, or rhGM-CSF (each at 100 units/ml) or control medium. In all cultures, enhanced expression of IL-2 receptor (CD25) and HLA-DR antigen was detected by flow cytometry on days 2 and 5 compared to day 0 (Table 2) . Basophils stimulated by rhIL-3 were found to bind more anti-IgE antibody (mAb E-124-2-8) than basophils maintained in control medium (see Fig. 2 ). No substantial change in reaction of CML basophils with mAbs BA-2 (CD9), MY-7 (CD13), VIM12 (CD11b), VIMD5 (CD15), MAX1, and YB5B8 was observed under any culture condition.
Effect of Cytokines on Anti-IgE-Induced Histamine Release from Basophils. Isolated granulocytes of four healthy individuals contained 5%, 6%, 2%, and 3% basophils. Isolated granulocytes were preincubated with (i) control medium, (ii) rhIL-3 (100 units/ml), (iii) rhIL-2 (100 units/ml), or (iv) rhGM-CSF (100 units/ml) for 30 min and then exposed for 30 min to control medium or to various concentrations of mAb specific for IgE. Granulocytes ofone donor were, in addition, exposed to 1 and 10 units of rhIL-3 per ml. Anti-IgE-induced histamine release from cells that were preincubated with control medium showed a high response (maximum release, 60.6% of total histamine) in donor 1, an intermediate response (28.2%) in donor 2, a low response (8.1%) in donor 3, and an intermediate response (29.5%) in donor 4. In all donors, preincubation with 100 units ofrhIL-3 per ml resulted in a 2-to 3-fold enhanced histamine release compared to control release (Figs. 3 and 4) . As shown in Fig. 4 , the effect of rhIL-3 on IgE-mediated histamine release was dose dependent. rhGM-CSF (100 units/ml) enhanced anti-IgEinduced histamine release, however, to a lesser extent than 100 units of rhIL-3 per ml (Fig. 3) . No effect of rhIL-2 on IgE-mediated histamine release was observed. No substantial histamine release (i.e., >5% of total histamine) was observed after exposure to any cytokine and maintenance in control medium. No change in total histamine values during preincubation of basophils with rhIL-3 was observed.
-DISCUSSION IL-3 is a T-cell-derived multipotential cytokine. The stimulating spectrum of human IL-3 includes different stages of Table 2 . Immunological surface marker profile of purified CML basophils after exposure to recombinant human cytokines in suspension CD/reactive -022  HLA-DR  3  5  7  10  9  17  22 25  20  11  12  8  9  Anti-TAC  CD25  23  43  41 49  37  36  41 59  43  21  26 34  18  MAX1  65 kDa  4  8  4  7  5  4  6  3  2  6  9  4  7   YBSB8   145-150 kDa  3  3  2  3  1  3  4  2  1  3  4  2  5   Control medium   1  1  2  3  2  1  1  2  2  2  2  1  1 Purified CML basophils were maintained in suspension in RPMI 1640 medium supplemented with 10%o fetal calf serum and recombinant cytokines or control medium. Cytokines (rhIL-2, rhIL-3, and rhGM-CSF) were added at a final concentration of 100 units/ml. Cells were cultured at 37°C in a humidified atmosphere of 5% C02/95% air. On days 0, 2, 5, and 9, cells were removed from cultures, washed twice, incubated with various mAbs, and then stained with a fluorescein isothiocyanate-labeled second step mAb. The percentage of reactive cells was evaluated by flow cytometry. One representative experiment is shown. hemopoietic maturation as well as multiple hemopoietic lineages (14) (15) (16) (32) (33) (34) . However, little is known so far about the distribution of specific receptors for IL-3 on the various human leukocyte subsets (35) . The present study provides evidence for the existence of specific IL-3 binding sites on the surface membrane of human basophils. In particular, CML basophils purified from two donors by mAbs and complement-mediated cell lysis were found to express a single class of about 500 and 2100 high-affinity IL-3 binding sites per cell. In approximation, these data agree with reported binding properties of murine IL-3 to its target cells (36, 37) . The difference in the number of IL-3 binding sites expressed on pure basophils enriched from the two CML donors might be explained by a different stage of cell maturation, since we Anti-IgE, pg/ml FIG. 4 . Dose dependency of enhancement of IgE-mediated histamine release by rhIL-3. Dextran-isolated granulocytes of one donor were exposed to various doses of rhIL-3 (o, 1 unit/ml; *, 10 units/ml; 9, 100 units/ml) or to control medium (-) for 30 min and thereafter to various concentrations of anti-IgE mAb E-124-2-8. Histamine release is expressed as percentage of total histamine. found a more immature morphology of CML basophils expressing the lower number (i.e., 500) of IL-3 receptors (data not shown).
Functional significance of expression of IL-3 binding sites on the basophil surface membrane was provided by the demonstration that purified CML basophils responded to rhIL-3 in a specific manner. First, rhIL-3 increased the [3H]thymidine uptake of CML basophils compared to control. Furthermore, after preloading with IgE, CML basophils pretreated with rhIL-3 bound more anti-IgE antibodies than CML basophils maintained in control medium. These Anti-IgE, pg/ml changes observed in CML basophils probably reflect a terminal phase of differentiation in those cell populations induced by rhIL-3. In contrast, no significant effect of rhGM-CSF or rhIL-2 on purified CML basophils was observed in this study. We also examined the effect of rhIL-2, rhIL-3, and rhGM-CSF on IgE-mediated histamine release from normal donors' blood basophils. Our results show that basophils are activated by rhIL-3 and rhGM-CSF (but not rhIL-2) for increased histamine releasability, which confirms the data obtained by Hirai et al. (13) . The exact mechanism for this increased response of normal blood basophils to anti-IgE antibodies caused by rhIL-3 and rhGM-CSF remains unknown. However, it might be deduced from our results that the IL-3 effect on normal human blood basophils is mediated through specific IL-3 binding sites.
In contrast to normal neutrophils, CML basophils were found to lack receptors for GM-CSF. This finding was unexpected because (i) basophils express a number of myeloid-associated surface membrane antigens (17) and (ii) because an effect of rhGM-CSF on IgE-induced basophil histamine release was seen by us as well as by Hirai and his colleagues. One possibility could be that normal donors' basophils express significant numbers of GM-CSF receptors, whereas CML basophils do not. Alternatively, GM-CSF molecules could have influenced basophil functions by indirect effects, possibly mediated by accessory cells present in granulocytic cell fractions. Another possibility could be that blood basophils express very low numbers of GM-CSF receptors, which were not detected in the present study but could mediate the observed effect.
